Anticancer Therapies – News and Features

Researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.

T-cell exhaustion can prevent optimal responses to immunotherapy, but a new cytokine "cocktail" may help increase T-cell survival.

Plant-derived nanoparticles, including those from rice bran, could be used as alternatives to traditional cancer treatments.

A new immunotherapy has been developed that localizes cytokines to tumors for weeks while preserving their activity.

Blocking oxygen-sensing enzymes in cancer cells can significantly halt acute myeloid leukemia in patient samples without affecting the production of normal blood cells.

Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.

Researchers, using an experiment that elucidated the function of tens of thousands of noncoding variants, discovered a link between functional mutations and genes linked to cancer pathways, as well as indicators to predict cancer patient survival.

New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy can successfully treat this rare and aggressive cancer.

Women with triple-negative breast cancer and high levels of immune cells in the tumor have a lower risk of relapse after surgery, even without chemotherapy.

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.